entity

Sphingolipid / ceramide signaling

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Sphingolipid / ceramide signaling: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
2Hypotheses
1Analyses
0Outgoing
4Incoming

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (4)

SourceRelationTypeStr
ST3GAL2participates_ingene0.49
ST8SIA1participates_ingene0.49
SGMS1participates_ingene0.46
SGMS2participates_ingene0.46

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Ganglioside Rebalancing Therapy 0.496 neurodegeneration Lipid raft composition changes in synapt
Sphingomyelin Synthase Activators for Raft Remodeling 0.468 neurodegeneration Lipid raft composition changes in synapt

Mentioning Analyses (1)

Scientific analyses that reference this entity

Lipid raft composition changes in synaptic neurodegeneration

neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.648

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Ceramide metabolism in oxidative and glycolytic muscle: Significance for lipid-i [PMID:41707846] Eurén T, Flockhart M, Strmeň T, Zhou X, Molecular metabolism 2026 0
Effect of Lactiplantibacillus mudanjiangensis strain isolated from post-fermente [PMID:41270786] Horie M, Tabata Y, Aiso C, Gotoh Y Beneficial microbes 2025 0
Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078] ["Ranjitha V", "Kumar A", "Kaalappa P"] Pharmaceutical research 2025 0
Identification of Anticancer Target Combinations to Treat Pancreatic Cancer and [PMID:40807373] ["Wang F", "Wu C", "Huang K"] Molecules (Basel, Switzerland) 2025 0
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] ["Sanadgol N", "Abedi M", "Hashemzaei M" Journal of nanobiotechnology 2025 0
Genetic variants in ganglioside synthesis enzymes associate with Alzheimer's dis [PMID:synthetic_29] Unknown Nat Genet 2024 0
CSF ganglioside ratios predict Alzheimer's disease progression and correlate wit [PMID:synthetic_27] Unknown JAMA Neurol 2023 0
Small-molecule modulation of ganglioside synthesis normalizes brain lipid compos [PMID:synthetic_26] Unknown Nat Neurosci 2023 0
Expression of Ceramide-Metabolizing Enzymes in the Heart Adipose Tissue of Cardi [PMID:37298446] Gruzdeva O, Dyleva Y, Belik E, Uchasova International journal of molec 2023 0
Glycosphingolipid-Glycan Signatures of Acute Myeloid Leukemia Cell Lines Reflect [PMID:35168327] ["Wang D", "Zhang T", "Maduni\u0107 K", Journal of proteome research 2022 0
Brain ganglioside composition is dysregulated in Alzheimer's disease with GM1 de [PMID:synthetic_24] Unknown Ann Neurol 2022 0
GM1 enhances BDNF-TrkB signaling and neuroprotection via lipid raft organization [PMID:synthetic_28] Unknown Mol Psychiatry 2022 0
GM1 ganglioside reduces amyloid-β aggregation and neurotoxicity in vitro [PMID:synthetic_23] Unknown J Neurosci 2021 0
Ganglioside composition varies widely across brain regions and cell types [PMID:synthetic_32] Unknown J Lipid Res 2021 0
Exogenous GM1 administration improves cognition and reduces pathology in APP/PS1 [PMID:synthetic_25] Unknown Neurobiol Aging 2020 0
Airway Resistance Caused by Sphingomyelin Synthase 2 Insufficiency in Response t [PMID:31517509] Gupta G, Baumlin N, Poon J, Ahmed B, Chi American journal of respirator 2020 0
Exogenous GM1 shows limited CNS bioavailability in clinical trials for Parkinson [PMID:synthetic_30] Unknown Mov Disord 2019 0
Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disru [PMID:30770781] Zheng K, Chen Z, Feng H, Chen Y, Zhang C Cell death & disease 2019 0
Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid R [PMID:31114500] Bilal F, Montfort A, Gilhodes J, Garcia Frontiers in pharmacology 2019 0
Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2. [PMID:30779713] Pekkinen M, Terhal PA, Botto LD, Henning JCI insight 2019 0